Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

被引：0
|
作者：
Zhenxin Zhang
Jian Wang
Shengdi Chen
Chunfeng Liu
Baorong Zhang
Rong Peng
Shenggang Sun
Xiangru Sun
Gang Zhao
Qiumin Qu
Yansheng Li
Suiqiang Zhu
Xiaoping Pan
Ming Shao
Yanping Wang
机构：
[1] Peking Union Medical College Hospital,Huashan Hospital
[2] Fudan University,Ruijin Hospital
[3] Shanghai Jiaotong University School of Medicine,The Second Affiliated Hospital, School of Medicine
[4] The Second Affiliated Hospital of Soochow University,West China Hospital
[5] Zhejiang University,Xijing Hospital
[6] Sichuan University,Tongji Hospital of Tongji Medical College
[7] Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,undefined
[8] Peking University First Hospital,undefined
[9] The First Affiliated Hospital of The Fourth Military Medical University,undefined
[10] The First Affiliated Hospital of Xi’an Jiaotong University,undefined
[11] Renji Hospital,undefined
[12] Shanghai Jiaotong University School of Medicine,undefined
[13] Huazhong University of Science and Technology,undefined
[14] Guangzhou First People’s Hospital,undefined
[15] School of Medicine,undefined
[16] South China University of Technology,undefined
[17] The First Affiliated Hospital of Guangzhou Medical University,undefined
[18] The Second Affiliated Hospital of Guangzhou Medical University,undefined
来源：
Translational Neurodegeneration | / 7卷
关键词：
Parkinson’s disease; Monoamine oxidase inhibitor; Rasagiline; Monotherapy; China;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhang, Zhenxin
    Wang, Jian
    Chen, Shengdi
    Liu, Chunfeng
    Zhang, Baorong
    Peng, Rong
    Sun, Shenggang
    Sun, Xiangru
    Zhao, Gang
    Qu, Qiumin
    Li, Yansheng
    Zhu, Suiqiang
    Pan, Xiaoping
    Shao, Ming
    Wang, Yanping
    TRANSLATIONAL NEURODEGENERATION, 2018, 7
  • [2] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
    Hattori, N.
    Takeda, A.
    Takeda, S.
    Nishimura, A.
    Kitagawa, T.
    Mochizuki, H.
    Nagai, M.
    Takahashi, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
  • [3] A randomized, placebo-controlled, double-blind, fixed-dose study of repaglinide.
    Cheatham, WW
    Strange, P
    DIABETOLOGIA, 1998, 41 : A235 - A235
  • [4] Safety and Efficacy of Epelsiban in the Treatment of Men with Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study
    Shinghal, Rajesh
    Barnes, Allison
    Mahar, Kelly M.
    Stier, Brendt
    Giancaterino, Lisa
    Condreay, Lynn D.
    Black, Libby
    McCallum, Stewart W.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (10): : 2506 - 2517
  • [5] Efficacy and safety of Rasagiline in levodopa-treated Korean Parkinson's disease patients with motor fluctuations: Randomized, placebo-controlled, double-blind study
    Yun, Ji Young
    Jeon, Beom
    Kim, Jae Woo
    Lee, Chong
    Kim, Jong-Min
    Cho, Jin Whan
    Sohn, Young
    Lee, Jee-Young
    MOVEMENT DISORDERS, 2014, 29 : S33 - S33
  • [6] Efficacy and safety of rotigotine transdermal patch in Chinese patients with early-stage Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Zhang, Z.
    Asgharnejad, M.
    Du, X.
    Surmann, E.
    Bauer, L.
    MOVEMENT DISORDERS, 2015, 30 : S137 - S138
  • [7] Rasagiline in Chinese Patients with Early-stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled, Delayed-start Trial
    Su, W.
    Liu, H. J.
    Wang, L. J.
    Ye, Q. Y.
    Cao, L.
    Zhou, H. Y.
    Luo, X. G.
    Ding, Z. T.
    Wang, T.
    Wang, Q.
    Ma, H. Z.
    Xu, E. H.
    Chen, H. B.
    MOVEMENT DISORDERS, 2023, 38 : S52 - S53
  • [8] RETRACTED ARTICLE: Safety and Efficacy of Dapoxetine in the Treatment of Premature Ejaculation: A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized Study
    Mohammad R Safarinejad
    Neuropsychopharmacology, 2008, 33 : 1259 - 1265
  • [9] Retraction Note: Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study
    Mohammad R. Safarinejad
    Neuropsychopharmacology, 2023, 48 : 978 - 978
  • [10] Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study
    Safarinejad, M. R.
    ANDROLOGIA, 2008, 40 (01) : 49 - 55
12345